ASD SPECIALTY HEALTHCARE, LLC

ASD Specialty Healthcare, LLC specializes in the procurement and fulfillment of specialized pharmaceutical preparations for federal healthcare programs, with a demonstrated focus on complex, niche medications requiring precise formulation and supply chain coordination. The company’s core capabilities center on the manufacturing and delivery of FDA-regulated pharmaceutical products, including liposomal inhalation therapies and targeted oral tablets such as WELIREG and BALVERSA, which are used in oncology and rare disease treatment. Their technical expertise includes compliance with current Good Manufacturing Practices (cGMP), cold chain logistics for sensitive biologics, and end-to-end pharmacy order fulfillment aligned with VA formulary requirements. A key differentiator is their ability to rapidly source and deliver specialty drugs with limited commercial availability, ensuring continuity of care for veterans with complex medical needs. The contractor maintains a consistent relationship with the Department of Veterans Affairs, providing mission-critical pharmaceuticals that support specialized treatment protocols within VA medical centers. Their work is tightly integrated into VA pharmacy systems, indicating a high degree of operational alignment with federal healthcare delivery standards and regulatory reporting requirements. The primary industry focus is pharmaceutical preparation manufacturing under NAICS 325412, placing the company within the specialty drug manufacturing sector, serving patients requiring customized or low-volume therapeutics. This positions them as a niche supplier in the federal market for high-cost, low-volume medications that are not routinely stocked by commercial distributors. ASD Specialty Healthcare, LLC operates as a private entity with no publicly disclosed certifications or geographic footprint. Their market positioning is defined by their ability to fulfill specialized pharmaceutical orders for federal healthcare programs, particularly where supply chain agility and regulatory precision are paramount.